{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T21:46:32Z","timestamp":1785879992469,"version":"3.56.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004608","name":"Jiangsu Province Natural Science Foundation","doi-asserted-by":"publisher","award":["BK20243034"],"award-info":[{"award-number":["BK20243034"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Jiangsu Province Natural Science Foundation","doi-asserted-by":"publisher","award":["BK20220671"],"award-info":[{"award-number":["BK20220671"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Jiangsu Province Natural Science Foundation","doi-asserted-by":"publisher","award":["BK20210913"],"award-info":[{"award-number":["BK20210913"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82471378"],"award-info":[{"award-number":["82471378"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304535"],"award-info":[{"award-number":["82304535"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82403846"],"award-info":[{"award-number":["82403846"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273207"],"award-info":[{"award-number":["82273207"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204541"],"award-info":[{"award-number":["82204541"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020770","name":"Jiangsu Provincial Medical Youth Talent","doi-asserted-by":"publisher","award":["JSTJ\\u22122025\\u2013496"],"award-info":[{"award-number":["JSTJ\\u22122025\\u2013496"]}],"id":[{"id":"10.13039\/501100020770","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.phrs.2026.108292","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T15:43:28Z","timestamp":1781279008000},"page":"108292","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Neutralizing LFA-1 alleviates acute lung injury by diminishing pulmonary retention of CAR-T cells"],"prefix":"10.1016","volume":"230","author":[{"given":"Rui","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangchun","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9263-6468","authenticated-orcid":false,"given":"Ming","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2026.108292_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114045","article-title":"Circadian rhythm in pharmacokinetics and its relevance to chronotherapy","volume":"178","author":"Dong","year":"2020","journal-title":"Biochem. Pharmacol."},{"issue":"5","key":"10.1016\/j.phrs.2026.108292_bib2","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/cpt.1115","article-title":"Disease-Associated Changes in Drug Transporters May Impact the Pharmacokinetics and\/or Toxicity of Drugs: A White Paper From the International Transporter Consortium","volume":"104","author":"Evers","year":"2018","journal-title":"Clin. Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.phrs.2026.108292_bib3","first-page":"888","article-title":"Absorption, Distribution, Metabolism, and Excretion of US Food and drug administration-approved antisense oligonucleotide drugs, drug metabolism and disposition: the biological fate of","volume":"50","author":"Migliorati","year":"2022","journal-title":"chemicals"},{"issue":"7","key":"10.1016\/j.phrs.2026.108292_bib4","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1080\/17425255.2020.1776700","article-title":"ADME and toxicity considerations for tramadol: from basic research to clinical implications","volume":"16","author":"Doostmohammadi","year":"2020","journal-title":"Expert. Opin. Drug. Metab. & Toxicol."},{"key":"10.1016\/j.phrs.2026.108292_bib5","doi-asserted-by":"crossref","first-page":"343","DOI":"10.14573\/altex.1610101","article-title":"T. Hartung, Evidence-based absorption, distribution, metabolism, excretion (ADME) and its interplay with alternative toxicity methods","author":"Tsaioun","year":"2016","journal-title":"Altex 33(4"},{"issue":"17","key":"10.1016\/j.phrs.2026.108292_bib6","article-title":"Anticancer drugs: recent strategies to improve stability profile, pharmacokinetic and pharmacodynamic properties","volume":"27","author":"Ioele","year":"2022","journal-title":"Mol. (Basel Switz. )"},{"issue":"4","key":"10.1016\/j.phrs.2026.108292_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15041132","article-title":"Pharmacokinetics and Pharmacodynamics of Antibody-Drug Conjugates Administered via Subcutaneous and Intratumoral Routes","volume":"15","author":"Chang","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.phrs.2026.108292_bib8","doi-asserted-by":"crossref","DOI":"10.1177\/1756285617737728","article-title":"Extended-release oral capsule of carbidopa-levodopa in Parkinson disease","volume":"11","author":"Margolesky","year":"2018","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"9","key":"10.1016\/j.phrs.2026.108292_bib9","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s40262-017-0511-y","article-title":"Pharmacokinetics of Rytary(\u00ae), An Extended-Release Capsule Formulation of Carbidopa-Levodopa","volume":"56","author":"Mittur","year":"2017","journal-title":"Clin. Pharmacokinet."},{"issue":"5","key":"10.1016\/j.phrs.2026.108292_bib10","doi-asserted-by":"crossref","first-page":"e370","DOI":"10.1016\/S2352-3026(20)30070-3","article-title":"Subcutaneous versus intravenous daratumumab in patients with relapsed or refractory multiple myeloma (COLUMBA): a multicentre, open-label, non-inferiority, randomised, phase 3 trial","volume":"7","author":"Mateos","year":"2020","journal-title":"Lancet Haematol."},{"issue":"10","key":"10.1016\/j.phrs.2026.108292_bib11","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.3324\/haematol.2021.279459","article-title":"Final analysis of the phase III non-inferiority COLUMBA study of subcutaneous versus intravenous daratumumab in patients with relapsed or refractory multiple myeloma","volume":"107","author":"Usmani","year":"2022","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.phrs.2026.108292_bib12","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.ccell.2025.03.019","article-title":"CAR-T therapy in solid tumors","volume":"43","author":"Du","year":"2025","journal-title":"Cancer Cell."},{"issue":"1","key":"10.1016\/j.phrs.2026.108292_bib13","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12935-024-03315-3","article-title":"Current challenges and therapeutic advances of CAR-T cell therapy for solid tumors","volume":"24","author":"Chen","year":"2024","journal-title":"Cancer Cell. Int."},{"key":"10.1016\/j.phrs.2026.108292_bib14","article-title":"Systemic toxicity of CAR-T therapy and potential monitoring indicators for toxicity prevention","volume":"15","author":"Li","year":"2024","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108292_bib15","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s40164-024-00542-2","article-title":"Infusion and delivery strategies to maximize the efficacy of CAR-T cell immunotherapy for cancers","volume":"13","author":"Gu","year":"2024","journal-title":"Exp. Hematol. & Oncol."},{"issue":"5","key":"10.1016\/j.phrs.2026.108292_bib16","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1038\/s41591-024-02893-z","article-title":"Intrathecal bivalent CAR T cells targeting EGFR and IL13R\u03b12 in recurrent glioblastoma: phase 1 trial interim results","volume":"30","author":"Bagley","year":"2024","journal-title":"Nat. Med."},{"issue":"9-10","key":"10.1016\/j.phrs.2026.108292_bib17","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1159\/000525052","article-title":"Treatment with Living Drugs: Pharmaceutical Aspects of CAR T Cells","volume":"107","author":"Holzinger","year":"2022","journal-title":"Pharmacology"},{"key":"10.1016\/j.phrs.2026.108292_bib18","doi-asserted-by":"crossref","first-page":"16011","DOI":"10.1038\/mto.2016.11","article-title":"Toxicity and management in CAR T-cell therapy","volume":"3","author":"Bonifant","year":"2016","journal-title":"Mol. Ther. oncolytics"},{"issue":"23","key":"10.1016\/j.phrs.2026.108292_bib19","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1182\/blood.2020008865","article-title":"Prognostic impact of corticosteroids on efficacy of chimeric antigen receptor T-cell therapy in large B-cell lymphoma","volume":"137","author":"Strati","year":"2021","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.phrs.2026.108292_bib20","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41573-024-01100-5","article-title":"Novel strategies to manage CAR-T cell toxicity","volume":"24","author":"Mulvey","year":"2025","journal-title":"Nat. Rev. Drug. Discov."},{"issue":"48","key":"10.1016\/j.phrs.2026.108292_bib21","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adg9721","article-title":"EpCAM-targeting CAR-T cell immunotherapy is safe and efficacious for epithelial tumors","volume":"9","author":"Li","year":"2023","journal-title":"Sci. Adv."},{"issue":"7","key":"10.1016\/j.phrs.2026.108292_bib22","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1016\/j.ymthe.2025.03.023","article-title":"IFN-\u03b3-mediated suppression of Caspase-7 exacerbates acute lung injury induced by CAR-T cells","volume":"33","author":"Hou","year":"2025","journal-title":"Molecular therapy journal American Society Gene Therapy"},{"issue":"1","key":"10.1016\/j.phrs.2026.108292_bib23","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2020.1806009","article-title":"Potential lung attack and lethality generated by EpCAM-specific CAR-T cells in immunocompetent mouse models","volume":"9","author":"Qin","year":"2020","journal-title":"Oncoimmunology"},{"issue":"8","key":"10.1016\/j.phrs.2026.108292_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/biom13081194","article-title":"LFA-1\/ICAM-1 Adhesion Pathway Mediates the Homeostatic Migration of Lymphocytes from Peripheral Tissues into Lymph Nodes through Lymphatic Vessels","volume":"13","author":"Guo","year":"2023","journal-title":"Biomolecules"},{"issue":"8","key":"10.1016\/j.phrs.2026.108292_bib25","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abg4485","article-title":"The magnitude of LFA-1\/ICAM-1 forces fine-tune TCR-triggered T cell activation","volume":"8","author":"Ma","year":"2022","journal-title":"Sci. Adv."},{"issue":"2","key":"10.1016\/j.phrs.2026.108292_bib26","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1189\/jlb.0412205","article-title":"TNF-\u03b1 and IFN-\u03b3 promote lymphocyte adhesion to endothelial junctional regions facilitating transendothelial migration","volume":"95","author":"Jaczewska","year":"2014","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.phrs.2026.108292_bib27","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12974-015-0346-0","article-title":"Pro-inflammatory TNF\u03b1 and IL-1\u03b2 differentially regulate the inflammatory phenotype of brain microvascular endothelial cells","volume":"12","author":"Carroll","year":"2015","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.phrs.2026.108292_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2023.117487","article-title":"ICAM-1 and VCAM-1: Gatekeepers in various inflammatory and cardiovascular disorders","volume":"548","author":"Singh","year":"2023","journal-title":"Clin. Chim. Acta Int. J. Clin. Chem."},{"key":"10.1016\/j.phrs.2026.108292_bib29","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.3389\/fimmu.2019.01078","article-title":"Cell Adhesion Molecules and Their Roles and Regulation in the Immune and Tumor Microenvironment","volume":"10","author":"Harjunp\u00e4\u00e4","year":"2019","journal-title":"Front. Immunol."},{"issue":"57","key":"10.1016\/j.phrs.2026.108292_bib30","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abd4344","article-title":"A cross-talk between CAR T cell subsets and the tumor microenvironment is essential for sustained cytotoxic activity","volume":"6","author":"Boulch","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.phrs.2026.108292_bib31","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.omto.2021.06.006","article-title":"Imaging CAR T-cell kinetics in solid tumors: Translational implications","volume":"22","author":"Skovgard","year":"2021","journal-title":"Mol. Ther. oncolytics"},{"issue":"2","key":"10.1016\/j.phrs.2026.108292_bib32","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1208\/s12248-025-01017-w","article-title":"Cellular Kinetics and Biodistribution of Adoptive T Cell Therapies: from Biological Principles to Effects on Patient Outcomes","volume":"27","author":"Li","year":"2025","journal-title":"AAPS J."},{"issue":"1","key":"10.1016\/j.phrs.2026.108292_bib33","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10555-024-10227-1","article-title":"Evolving strategies for addressing CAR T-cell toxicities","volume":"44","author":"Rankin","year":"2024","journal-title":"Cancer Metastas-.-. Rev."},{"issue":"4","key":"10.1016\/j.phrs.2026.108292_bib34","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ads3403","article-title":"Microenvironment actuated CAR T cells improve solid tumor efficacy without toxicity","volume":"11","author":"Vogt","year":"2025","journal-title":"Sci. Adv."},{"issue":"3","key":"10.1016\/j.phrs.2026.108292_bib35","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s10555-024-10185-8","article-title":"vivo manufacture and manipulation of CAR-T cells for better druggability","volume":"43","author":"Hou","year":"2024","journal-title":"Cancer Metastas-.-. Rev."},{"issue":"1","key":"10.1016\/j.phrs.2026.108292_bib36","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s12967-023-04041-6","article-title":"Tuning CARs: recent advances in modulating chimeric antigen receptor (CAR) T cell activity for improved safety, efficacy, and flexibility","volume":"21","author":"Celichowski","year":"2023","journal-title":"J. Transl. Med."},{"issue":"4","key":"10.1016\/j.phrs.2026.108292_bib37","first-page":"301","article-title":"Advances in strategies to improve the immunotherapeutic efficacy of chimeric antigen receptor-T cell therapy for lymphoma","volume":"22","author":"Yu","year":"2025","journal-title":"Cancer Biol. & Med."},{"issue":"11","key":"10.1016\/j.phrs.2026.108292_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24119115","article-title":"Strategies for reducing toxicity and enhancing efficacy of chimeric antigen receptor t cell therapy in hematological malignancies","volume":"24","author":"Wang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2026.108292_bib39","article-title":"vivo chimeric antigen receptor (CAR)-T cell therapy","author":"Bot","year":"2025","journal-title":"Nat. Rev. Drug. Discov."},{"issue":"8","key":"10.1016\/j.phrs.2026.108292_bib40","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adj6251","article-title":"Enhancing the safety of CAR-T cell therapy: Synthetic genetic switch for spatiotemporal control","volume":"10","author":"Lu","year":"2024","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.phrs.2026.108292_bib41","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13045-019-0763-0","article-title":"Engineering switchable and programmable universal CARs for CAR T therapy","volume":"12","author":"Liu","year":"2019","journal-title":"J. Hematol. & Oncol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108292_bib42","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2025.2558403","article-title":"vivo CAR-T cell therapy: New breakthroughs for cell-based tumor immunotherapy","volume":"21","author":"Huang","year":"2025","journal-title":"Human. Vaccin. & Immunother."},{"key":"10.1016\/j.phrs.2026.108292_bib43","doi-asserted-by":"crossref","first-page":"655","DOI":"10.2147\/ITT.S519616","article-title":"Current Advances and Challenges in CAR-T Therapy for Hematological and Solid Tumors","volume":"14","author":"Zhang","year":"2025","journal-title":"ImmunoTargets Ther."},{"issue":"4","key":"10.1016\/j.phrs.2026.108292_bib44","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/s41591-023-02234-6","article-title":"A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy","volume":"29","author":"Stein-Thoeringer","year":"2023","journal-title":"Nat. Med."},{"issue":"22","key":"10.1016\/j.phrs.2026.108292_bib45","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.186268","article-title":"Affinity-tuned mesothelin CAR T cells demonstrate enhanced targeting specificity and reduced off-tumor toxicity","volume":"9","author":"Yang","year":"2024","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.phrs.2026.108292_bib46","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12943-024-01952-w","article-title":"Affinity fine-tuning anti-CAIX CAR-T cells mitigate on-target off-tumor side effects","volume":"23","author":"Wang","year":"2024","journal-title":"Mol. Cancer"},{"issue":"705","key":"10.1016\/j.phrs.2026.108292_bib47","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.add7900","article-title":"Systematic single amino acid affinity tuning of CD229 CAR T cells retains efficacy against multiple myeloma and eliminates on-target off-tumor toxicity","volume":"15","author":"Vander Mause","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.phrs.2026.108292_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1032403","article-title":"The affinity of antigen-binding domain on the antitumor efficacy of CAR T cells: moderate is better","volume":"13","author":"Mao","year":"2022","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.phrs.2026.108292_bib49","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005678","article-title":"Dose-response correlation for CAR-T cells: a systematic review of clinical studies","volume":"10","author":"Rotte","year":"2022","journal-title":"J. Immunother. Cancer"},{"issue":"9","key":"10.1016\/j.phrs.2026.108292_bib50","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1111\/bcp.14281","article-title":"Chimeric antigen receptor T-cell therapies: Optimising the dose","volume":"86","author":"Dasyam","year":"2020","journal-title":"Br. J. Clin. Pharmacol."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826002070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826002070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T21:03:52Z","timestamp":1785877432000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661826002070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":50,"alternative-id":["S1043661826002070"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108292","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neutralizing LFA-1 alleviates acute lung injury by diminishing pulmonary retention of CAR-T cells","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108292","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108292"}}